Published on 24 Jan 2024 on Simply Wall St. via Yahoo Finance
Insiders own 28% of Annovis Bio, Inc. (NYSE:ANVS) shares but individual investors control 57% of the...
Key Insights
Significant control over Annovis Bio by individual investors implies that the general public has more power to influence management and governance-related decisionsA total of 25 investors have a majority stake in the company with 43% ownership Insider ownership in Annovis Bio is 28%
If you want to know who really controls Annovis Bio, Inc. (NYSE:ANVS), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 57% to be precise, is individual investors. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).